POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XP9_C_1WEC706_1 (TRANSPORTER)	2d3v	LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR SUBFAMILY A MEMBER 5 ISOFORM 1 (Homo sapiens)	4 / 4	PHE A 130 ASP A 128 GLY A 175 SER A 146	None	1.23A	17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XP9_C_1WEC706_1 (TRANSPORTER)	2z65	LYMPHOCYTE ANTIGEN 96 TOLL-LIKE RECEPTOR 4, VARIABLE LYMPHOCYTE RECEPTOR B (Eptatretus burgeri; Homo sapiens)	4 / 4	PHE A  63 ASP A  84 GLY C 110 SER A  62	None	1.38A	20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XP9_C_1WEC706_1 (TRANSPORTER)	3b2d	CD180 ANTIGEN LYMPHOCYTE ANTIGEN 86 (Homo sapiens)	4 / 4	PHE A  62 ASP A  83 GLY C 117 SER A  61	None	1.36A	22.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XP9_C_1WEC706_1 (TRANSPORTER)	3lmk	METABOTROPIC GLUTAMATE RECEPTOR 5 (Homo sapiens)	4 / 4	PHE A 277 ASP A 305 GLY A 227 SER A 304	None GLU  A 506 (-2.7A) None None	1.39A	22.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XP9_C_1WEC706_1 (TRANSPORTER)	4hwe	FAB HEAVY CHAIN (Homo sapiens)	4 / 4	PHE H 106 ASP H 107 GLY H  36 SER H 105	None	1.28A	17.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XP9_C_1WEC706_1 (TRANSPORTER)	5cni	METABOTROPIC GLUTAMATE RECEPTOR 2 (Homo sapiens)	4 / 4	PHE A 269 ASP A 295 GLY A 220 SER A 294	None GGL  A 601 (-3.0A) None None	1.42A	23.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XP9_C_1WEC706_1 (TRANSPORTER)	5kzn	METABOTROPIC GLUTAMATE RECEPTOR 2 (Homo sapiens)	4 / 4	PHE A 269 ASP A 295 GLY A 220 SER A 294	None	1.45A	22.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XP9_C_1WEC706_1 (TRANSPORTER)	6bdz	DISINTEGRIN AND METALLOPROTEINASE DOMAIN-CONTAINING PROTEIN 10 (Homo sapiens)	4 / 4	PHE A 432 ASP A 394 GLY A 386 SER A 433	None	1.25A	8.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XP9_C_1WEC706_1 (TRANSPORTER)	6bsz	METABOTROPIC GLUTAMATE RECEPTOR 8 (Homo sapiens)	4 / 4	PHE A 281 ASP A 309 GLY A 231 SER A 308	None GGL  A 601 (-2.8A) None None	1.24A	10.69